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Activation of the aryl hydrocarbon receptor (AhR) by its prototypic ligand, 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), mediates potent suppression of T-cell dependent
immune responses. The suppressive effects of TCDD occur early during CD4+ T-cell dif-
ferentiation in the absence of effects on proliferation and have recently been associated
with the induction of AhR-dependent regulatory T-cells (Treg). Since AhR functions as a
ligand-activated transcription factor, changes in gene expression induced by TCDD during
the early stages of CD4+ T-cell differentiation are likely to reflect fundamental mechanisms
of AhR action. A custom panel of genes associated with T-cell differentiation was used to
query changes in gene expression induced by exposure to 1 nM TCDD. CD4+ T-cells from
AhR+/+ and AhR−/− mice were cultured with cytokines known to polarize the differentia-
tion of T-cells to various effector lineages. Treatment with TCDD induced the expression of
Cyp1a1, Cyp1b1, and Ahrr in CD4+ T-cells from AhR+/+ mice under all culture conditions,
validating the presence and activation of AhR in these cells. The highest levels of AhR
activation occurred underTh17 conditions at 24 h andTr1 conditions at 48 h. Unexpectedly,
expression levels of most genes associated with early T-cell differentiation were unaltered
by AhR activation, including lineage-specific genes that drive CD4+ T-cell polarization. The
major exception was AhR-dependent up-regulation of Il22 that was seen under all culture
conditions. Independent of TCDD, AhR down-regulated the expression of Il17a and Rorc
based on increased expression of these genes in AhR-deficient cells across culture condi-
tions.These findings are consistent with a role for AhR in down-regulation of inflammatory
immune responses and implicate IL-22 as a potential contributor to the immunosuppressive
effects of TCDD.
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sion, IL-22
INTRODUCTION
Activation of the transcription factor, aryl hydrocarbon recep-
tor (AhR), by the prototypic ligand 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) has been shown to exert potent immunosup-
pressive effects in a variety of T-cell dependent disease mod-
els. TCDD suppresses Th1-dependent autoimmune diseases such
as Type 1 diabetes in the non-obese diabetic (NOD) mouse
(Kerkvliet et al., 2009) and experimental autoimmune uveoretini-
tis (Zhang et al., 2010). TCDD also suppresses the Th17-mediated
response in both experimental autoimmune encephalomyelitis
(EAE) and colitis (Quintana et al., 2008; Benson and Shepherd,
2011). These potent immunosuppressive effects are also conserved
in non-autoimmune disease models. The Th1-driven cytotoxic T-
lymphocyte (CTL) and alloantibody responses to allogeneic P815
tumor cells are dose-dependently suppressed by TCDD treatment
(Kerkvliet et al., 1996), as are CTL and antibody responses to
influenza virus infection (Warren et al., 2000). Treatment with
TCDD also suppresses Th2-dependent cytokine and OVA-specific
antibody production (Shepherd et al., 2000; Nohara et al., 2002),
as well as several Th2-dependent allergic diseases including atopic
dermatitis (Fujimaki et al., 2002), dust mite-induced asthma
(Luebke et al., 2001), and peanut allergy (Schulz et al., 2011).
One of the mechanisms by which TCDD suppresses adaptive
immunity occurs via activation of AhR in differentiating CD4+
T-cells. This was demonstrated using an acute parent-into-F1
graft-versus-host (GVH) model wherein the suppression of donor
CTL development was contingent upon the donor CD4+ T-cells
expressing AhR (Kerkvliet et al., 2002). Furthermore, optimal sup-
pression of the CTL response occurred when TCDD was admin-
istered within 3 days of alloantigen stimulation – the time dur-
ing which donor CD4+ T-cells undergo differentiation (Kerkvliet
et al., 1996). Phenotypic and functional analysis of the differenti-
ating allospecific donor cells suggested that AhR activation was
driving the development of an immunosuppressive regulatory
T-cell (Treg), characterized by a CD4+CD25highFoxp3negCTLA-
4+CD62LlowIL-10+ phenotype (Funatake et al., 2005; Marshall
et al., 2008). Subsequently, TCDD has also been shown to induce
Foxp3+ Tregs and Tr1 cells in vitro (Apetoh et al., 2010; Gandhi
et al., 2010) and to increase the frequency of Foxp3+ CD4+ T-cells
in vivo in several models of immune-mediated disease (Quintana
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et al., 2008; Kerkvliet et al., 2009; Takamura et al., 2010; Zhang
et al., 2010; Benson and Shepherd, 2011; Schulz et al., 2011; Singh
et al., 2011).
Based on its role as a transcription factor, activation of AhR
in CD4+ T-cells may directly alter CD4+ T-cell differentiation by
influencing gene expression during early differentiation events.
The likelihood of such effects is high given the large number
of immune-related genes that contain dioxin response elements
(DRE; Sun et al., 2004; Frericks et al., 2008; Kerkvliet, 2009). In the
present studies, we characterized the influence of TCDD-activated
AhR on gene expression during CD4+ T-cell differentiation under
Th0, Th1, Treg, Tr1, and Th17 polarizing conditions. We utilized
a custom panel of 48 genes that have been associated with AhR
activation, T-cell differentiation, and/or Treg induction (Table 1).
CD4+ T-cells were obtained from AhR+/+ and AhR-deficient
(AhR−/−) mice, allowing us to validate the AhR-dependence of
TCDD’s effects. In addition,differences in gene expression between
vehicle-treated cultures of AhR+/+ and AhR−/− CD4+ T-cells
identified genes that are regulated by AhR during T-cell activation
in the absence of an exogenous ligand.
MATERIALS AND METHODS
ANIMALS
B6.PL-Thy1a/CyJ mice (Thy1.1+/+, AhR+/+) and B6.129-
AhRtm1Bra/J (Thy1.1+/+,AhR−/−) mice were bred and maintained
under specific pathogen-free conditions at the Laboratory Animal
Resource Center at Oregon State University (Corvallis, OR, USA).
All animal procedures were approved by the Institutional Animal
Care and Use Committee.
CD4+ T-CELL CULTURES
Spleens were aseptically removed and processed into single-cell
suspensions via dissociation between the frosted ends of micro-
scope slides. Red blood cells and dead cells were removed by
hypotonic water lysis. CD4+ T-cells were isolated by negative
selection using a CD4+ T-cell isolation kit and an autoMACS sep-
arator (Miltenyi Biotec; Auburn, CA, USA). T-cells were cultured
in RPMI 1640 media (Invitrogen; Carlsbad, CA, USA), supple-
mented with 10% fetal bovine serum (HyClone; Logan, UT, USA),
10 mM HEPES (Invitrogen), 50µg/ml gentamicin (Invitrogen),
and 50µM 2-β-mercaptoethanol (Sigma; St. Louis, MO, USA).
At the time of culture initiation, cells were treated with 1 nM
TCDD (dissolved in DMSO) or 0.001% DMSO (vehicle). The
1 nM concentration of TCDD used in these studies was sufficient
to induce maximum activation of AhR in T-cells as reflected in
expression of known AhR-regulated genes Cyp1a1, Cyp1b1, and
Ahrr (unpublished data).
CD4+ T-cells (1× 106 cells/well) were activated with soluble
anti-CD3 (0.5µg/ml) and anti-CD28 (2.5µg/ml) or plate-bound
anti-CD3 (2µg/ml) and anti-CD28 (2µg/ml) in a 24-well plate.
For Th1 conditions, anti-IL-4 (10µg/ml) and IL-12 (3 ng/ml)
was added to each well. For Treg polarizing conditions, TGFβ1
(3 ng/ml) was added. In addition to TGFβ1, IL-27 (25 ng/ml), or
IL-6 (15 ng/ml) was added for Tr1 or Th17 polarizing conditions,
respectively. All reagents for T-cell polarization were purchased
from eBioscience. T-cells cultured under Th0 conditions received
no exogenous cytokines.
Table 1 | Panel of genes used to evaluate AhR regulation of gene
expression in CD4+ T-cells.
Gene symbol Gene name RefSeq
A2br Adora2b NM_007413
Actb Actb NM_007393.3
Ahr AhR NM_013464.4
Ahrr AhRR NM_009644
Bach2 Bach2 NM_007521
Cd27 CD27 NM_001033126.2
Cd40lg Tnfsf5 NM_011616.2
Cd69 CD69 NM_001033122
Ctla4 CTLA-4 NM_009843.3
Cyp1a1 Cyp1a1 NM_009992.2
Cyp1b1 Cyb1b1 NM_009994.1
Entpd1 Entpd1/CD39 NM_009848
Fasl Tnfsf6 NM_010177.3
Foxp3 Foxp3 NM_054039.1
Gata3 Gata3 NM_008091.3
Gzmb Gzmb NM_013542
Hmox1 Hmox1 NM_010442.1
Icos ICOS NM_017480.1
Ifng IFNγ NM_008337.1
Il2 IL-2 NM_008366.2
Il4 IL-4 NM_021283.1
Il6 IL-6 NM_031168.1
Il10 IL-10 NM_010548.1
Il10ra IL-10Ra NM_008348.2
Il12a IL-12a NM_008351.1
Il12b IL-12b NM_008352.2
Il12rb2 IL-12Rβ2 NM_008354.1
Il17a IL-17A NM_010552
Il-21 IL-21 NM_021782.2
Il-21r IL-21R NM_021887.1
Il22 IL-22 NM_016971.1
Il27ra IL-27Rα NM_016671.2
Il2ra IL-2Rα/CD25 NM_008367.2
Maf c-MAF NM_001025577.2
Nfatc2 Nfatc2 NM_010899.2
Nfe2l2 Nfe212 NM_010902
Pdcd1 PD-1 NM_008798.2
Prdm1 Prdm1 NM_007548
Rorc RORγ NM_011281.1
Socs3 Socs3 NM_007707.2
Stat4 Stat4 NM_011487
Tbx21 Tbx21/Tbet NM_019507.1
Tgfb1 TGFβ1 NM_011577.1
Tgfb3 TGFβ3 NM_009368.1
Tgfbr1 TGFβR1 NM_009370.2
Tgfbr2 TGFβR2 NM_009371.2
Tnf TNFα NM_013693.1
Tnfrsf4 Tnfrsf4/OX40 NM_011659
Genes were chosen based on association withT-cell activation and differentiation,
or genes that have been previously identified to be responsive to TCDD in vivo.
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For some genes (Il22, Il17a, Rorc), protein levels were also mea-
sured. Whole splenocytes or purified CFSE-labeled CD4+ T-cells
were cultured under Th17 conditions. After 48 h, cells were treated
for 6 h with a Cell Stimulation Cocktail (eBioscience) contain-
ing phorbol 12-myristate 13-acetate, ionomycin, Brefeldin A, and
monensin. The cells were then stained for intracellular protein
prior to flow cytometric analysis as described below. Supernatants
were collected for ELISA analysis.
RNA ISOLATION AND qPCR
CD4+ T-cells were harvested at 24 and 48 h and flash frozen in
liquid nitrogen. Cell pellets were stored at −80˚C. RNA was iso-
lated using the RNeasy Mini Kit #74104 (Qiagen; Valencia, CA,
USA), with on-column DNase digestion (Qiagen #79254) per-
formed twice to ensure complete elimination of genomic DNA.
RNA concentrations and purity were determined using the Nan-
oDrop ND-1000 UV-Vis Spectrophotometer (ThermoScientific).
The Reaction Ready First Strand cDNA synthesis kit #C-01/C-03
(SA Biosciences, formerly SuperArray; Frederick, MD, USA) was
used to synthesize cDNA in a two-step PCR reaction. A mini-
mum of 200 ng RNA was used for all reactions. Following reverse
transcription, samples were stored at−80˚C.
An ABI PRISM 7500 Real-Time PCR system (Applied Biosys-
tems) was used for all qPCR reactions. SYBR Green/ROX qPCR
Master Mix (SA Bioscience) was used to prepare a 25µl reaction
mix consisting of 12.5µl master mix, cDNA equivalent to 2 ng
RNA, 1µl primer, and RNase-free H20 to obtain the final vol-
ume. All primers were obtained from SA Biosciences. Sequence
accession numbers are shown in Table 1. The qPCR settings were
as follows: 10 min at 95˚C, followed by 40 cycles of 15 s at 95˚C,
followed by 1 min at 60˚C. This was followed by a standard dissoci-
ation step of 15 s at 95˚C to generate a melting curve. A no-reverse
transcription (NRT) control was included to validate the absence
of genomic DNA from all samples.
qPCR DATA ANALYSIS
Data were analyzed using ABI 7500 analysis software. Genes that
were not detected within 40 cycles received a value of 40. Cycle
numbers were then normalized to Actb to calculate ∆Ct. The
data were analyzed as either 1/∆Ct or 1/∆Ct× 100; all other data
were presented as fold change. Fold changes were calculated by the
following formulas:
∆Ctexperimental −∆Ctcontrol = ∆∆Ct
2(−∆∆Ct ) = fold change
When analyzing gene expression across polarizing conditions,
fold changes were calculated relative to Th0 as follows:
∆Ct(Th1;Th17;Treg ;Trl) −∆CtTh0 = ∆∆Ct
2(−∆∆Ct ) = fold change
FLOW CYTOMETRIC ANALYSIS
The following antibodies were purchased from eBioscience: CD4-
PE (GK1.5), IL-22-PE (1H8PWSR), IL-17A-APC (eBio17B7),
and RORγ-PE (AFKJS). CD4-APC (GK1.5) and carboxyfluo-
rescein succinimidyl ester (CFSE) were purchased from Invit-
rogen. Splenocytes or purified CFSE-labeled CD4+ T-cells were
resuspended in PAB (PBS, 1% BSA, 0.1% sodium azide), and incu-
bated with PE- or APC-labeled anti-CD4 antibody for 10 min.
After two washes, cells were resuspended in Fixable Viability Dye
efluor 780 (eBioscience) for 30 min. The BD Cytofix/Cytoperm
buffer set or the Foxp3 Staining Buffer set (eBioscience) was used
for intracellular staining. Control samples that contained all of the
antibodies except the one of interest (fluorescence minus one) were
used as negative staining controls. A minimum of 150,000 viable
CD4+ T-cells were collected per sample on a Beckman Coulter
FC-500 flow cytometer. Compensation and analysis of data were
performed in WinList (Verity Software, Version 6.0).
ELISA
Supernatants from purified CD4+ T-cells and splenocyte cultures
were collected after 48 h. IL-22 production was quantified using
the IL-22 Ready-Set-Go® ELISA kit from eBioscience, according
to manufacturer’s instructions.
STATISTICAL ANALYSIS
All treatment groups consisted of a minimum of three biolog-
ical replicates (two mice per replicate), except where indicated.
Each biological sample was treated with vehicle or TCDD in sep-
arate wells. Differences due to TCDD treatment were determined
using a paired Student’s t -test. For comparisons between AhR+/+
and AhR−/− CD4+ T-cells, or between culture conditions, a non-
paired Student’s t -test was used. Values were considered statisti-
cally significant at p≤ 0.05, in conjunction with a fold change of
≥2 between treatment groups. For Il22 analysis across treatments,
a linear mixed model was utilized using the Mixed procedure of
SAS (v. 9.2).
RESULTS
ARYL HYDROCARBON RECEPTOR IS PRESENT AND
TRANSCRIPTIONALLY ACTIVE DURING EARLY DIFFERENTIATION OF
CD4+ T-CELLS
Ahr message was detected in CD4+ T-cells cultured under all
conditions. Cells activated for 24 h in the absence of exogenous
cytokines (Th0 conditions) expressed Ahr at a level comparable to
that of non-activated cells, indicating that expression of Ahr is not
up-regulated due to T-cell receptor activation alone (Figure 1A).
Likewise, neither Th1 nor Tr1 polarizing conditions produced a
significant increase in Ahr expression. In contrast, Treg conditions
induced a fourfold increase and Th17 conditions induced a 78-fold
increase in Ahr expression at 24 h (Figure 1B).
At 48 h, Ahr expression under Th0 conditions was equiva-
lent to the level of expression seen at 24 h, while expression
was up-regulated by 5.6-fold under Th1 conditions and 7.4-fold
under Treg polarizing conditions (Figure 1C). Expression of Ahr
declined under Th17 conditions but remained significantly up-
regulated (21-fold) compared to Th0 conditions. Ahr expression
was highest at 48 h under Tr1 conditions with a fold change of 92
relative to Th0 conditions.
To determine if the level of Ahr message present under differ-
ent culture conditions was indicative of AhR protein, the abil-
ity of TCDD to increase expression of known AhR-regulated
genes was examined. Addition of TCDD per se did not influ-
ence Ahr expression except for a small increase that was noted
under Treg conditions at 24 h (Table 2). In contrast, addition
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FIGURE 1 | Expression ofAhr and Cyp1a1 in CD4+ T-cells cultured
under various conditions. (A) Basal expression of Ahr (1/∆Ct) in CD4+
T-cells cultured for 4 h without stimulation or 24 h following stimulation with
anti-CD3/anti-CD28. (B,C) Ahr expression in CD4+ T-cells cultured for 24 or
48 h with polarizing cytokines as described in Section “Materials and
Methods.” Data are presented as fold change relative to Th0 vehicle
conditions at 24 or 48 h. (D,E) Expression of Cyp1a1 in vehicle- and
TCDD-treated CD4+ T-cells cultured for 24 or 48 h under different polarizing
conditions. Data are presented as fold change relative to the vehicle-treated
Th0 condition at 24 or 48 h. *p≤0.05 relative to either vehicle or TCDD Th0
control within that time point. †p≤0.05 relative to the TCDD-treated Th0
condition at 24 or 48 h. Error bars indicate the mean±SEM; n=3−4
biological replicates.
of TCDD significantly up-regulated Cyp1a1 expression under
all conditions tested (Figures 1D,E), with good correlation
between the levels of expression of Cyp1a1 and Ahr at both
24 and 48 h (Figure 1). A similar correlation was observed
between expression levels of Ahr and expression levels of the
AhR-regulated genes Cyp1b1 and Ahrr (Figure A1 in Appen-
dix). These results indicate that sufficient AhR is expressed
in CD4+ T-cells cultured under any condition to be able to
respond to 1 nM TCDD and alter expression of AhR-regulated
genes.
Table 2 | Influence ofTCDD onAhr expression in CD4+ T-cells cultured
under different polarizing conditions.
24 h 48 h
Average ∆Ct‡ Fold change Average ∆Ct Fold change
VEH TCDD TCDD/VEH VEH TCDD TCDD/VEH
Th0 11.2 12.4 −2.3† 12.2 13.4 −2.4†
Th1 12.0 11.2 1.7 10.7 11.1 −1.3
Treg 9.8 10.8 −2.0* 8.0 9.4 −2.8†
Tr1 12.3 12.8 −1.5 6.7 6.9 −1.2
Th17 4.9 5.3 −1.4 9.0 9.9 −2.0
‡Average cycle number of 3−4 biological replicates, corrected to β-actin.
†NSD; *p≤0.05.
While TCDD-induced relatively high levels of Cyp1a1, low lev-
els of Cyp1a1 were also seen in the absence of an exogenous ligand
in CD4+ T-cells cultured under Treg, Tr1, and Th17 polarizing
conditions at both 24 and 48 h (Figures 1D,E). These results
suggest that the cytokine milieu either contains or is capable of
inducing the formation of an AhR ligand in the responding T-
cells. Interestingly very low but detectable Cyp1a1 expression was
also seen in AhR-deficient cells especially at 48 h under all polariz-
ing conditions (Figure 2). Addition of TCDD did not up-regulate
this expression, validating the absence of functional AhR protein
in AhR−/− cells (Figure 2), but implicating an AhR-independent
pathway for Cyp1a1 expression.
EFFECT OF AHR ACTIVATION BY TCDD ON EXPRESSION OF GENES
INVOLVED IN CD4+ T-CELL DIFFERENTIATION
The pattern of gene expression observed under the various polar-
izing conditions was consistent with early differentiation events
specific to different CD4+ T-cell subsets (Figure 3; Zhou et al.,
2009; Hermann-Kleiter and Baier, 2010). Under Th1 polarizing
conditions, the transcription factor Tbet was up-regulated at 48 h,
and the associated cytokine Ifng was up-regulated at 24 and 48 h
when compared to expression levels in non-polarized (Th0) cells.
The up-regulation of these Th1-associated genes was concurrent
with the down-regulation of Gata3, also consistent with Th1 differ-
entiation. Similarly, the transcription factor for T-regulatory cells,
Foxp3, and the associated Treg marker Cd39 were up-regulated
under Treg polarizing conditions, while Tr1 polarizing conditions
induced the expression of Maf and Il10. Foxp3 expression was
also up-regulated under Tr1 polarizing conditions at 48 h, albeit
to a lesser extent than that seen under Treg polarizing condi-
tions. As expected Th17 polarizing conditions produced increased
expression of Rorc and Il17 at 24 and 48 h.
Surprisingly, activation of AhR by TCDD did not significantly
alter expression of any of the master regulator genes associated
with CD4+ T-cell polarization or other genes associated with
polarization (Figure 3). In fact, expression of only one gene in the
panel of genes tested, Il22, was clearly altered by treatment with
TCDD, and this effect was seen under all conditions except Tr1
(Table 3). When analyzed over all conditions except Tr1, expres-
sion of Il22 was significantly increased in the presence of TCDD at
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FIGURE 2 | Expression of Cyp1a1 in AhR−/− CD4+ T-cells. Data are
presented as fold change relative to AhR+/+ CD4+ T-cells cultured under
vehicle-treated Th0 conditions for (A) 24 or (B) 48 h. Error bars indicate the
mean±SEM; n=3−4 biological replicates, except for 24 h AhR−/− Treg and
Th17 conditions, and 48 h AhR−/− Treg and Tr1 conditions, where n=2.
*p≤0.05; ND=not detected within 40 cycles.
both 24 (p= 0.03) and 48 h (p< 0.001). The level of Il22 expres-
sion was highest under Th1 conditions in vehicle-treated cells, and
addition of TCDD further increased expression (Figure 4), while
the greatest induction of Il22 expression by TCDD (17.6-fold)
occurred under Th17 conditions at 48 h (Table 3). The minimal
expression of Il22 under Tr1 conditions was surprising given the
high level of Ahr expressed in these cells at 48 h and suggested that
the presence of IL-27 as a polarizing cytokine inhibits Il22 tran-
scription. In fact, Rutz et al. (2011) recently showed that the induc-
tion of c-Maf by IL-27 results in downstream repression of Il22.
Analysis of AhR−/− CD4+ T-cells showed no significant increase
in Il22 expression upon treatment with TCDD at either 24 or 48 h
under any polarizing condition, verifying that the up-regulation
of Il22 by TCDD was dependent on AhR activation (Table 3).
To determine if AhR-mediated regulation of Il22 was con-
served at the level of protein, purified CD4+ T-cells or whole
splenocytes were cultured with or without TCDD for 48 h under
Th17 polarizing conditions. IL-22 was measured in CD4+ T-
cells and in culture supernatants. As shown in Figure 5A, a
small population of CD4+ T-cells was found to express IL-22
in vehicle-treated cultures. Addition of TCDD increased the per-
centage of IL-22+ cells (p= 0.06) and the amount of IL-22 pro-
duced on a per cell basis (p= 0.08) as measured by the median
FIGURE 3 | Expression of genes associated with specific polarization in
CD4+ T-cells treated with vehicle (white bar) orTCDD (black bar) for (A)
24 or (B) 48 h. Data are presented as 1/∆Ct×100. Gene expression under
Th0 conditions (no polarizing cytokines) is presented for comparison with
gene expression under specific polarizing conditions as described in
Section “Materials and Methods.” Error bars represent the mean±SEM;
n=3−4 biological replicates. *p≤0.05.
fluorescence intensity (MFI). IL-22 was also detected in super-
natants from cultures of purified CD4+ T-cells. TCDD-treated
samples had an average of 28 pg/ml compared to <8 pg/ml (the
reporting limit) in vehicle-treated cultures (Figure 5B). Likewise,
when whole splenocytes were cultured, treatment with TCDD
increased the frequency of IL-22+ CD4+ T-cells (p= 0.05) and
the MFI (p< 0.001; Figure 5C). Significantly more IL-22 was
found in supernatants from whole splenocytes consistent with a
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Table 3 | Influence ofTCDD on Il22 expression in AhR+/+ and AhR−/−
CD4+ T-cells activated under different polarizing conditions.
Polarizing condition AhR+/+
TCDD/VEH
AhR−/−
TCDD/VEH
24 h 48 h 24 h 48 h
Th0 2.5 3.8 1.3 −1.8
Th1 2.3 13.7 −1.4 3.1
Treg 2.2 6.4 1.5 1.0
Tr1 −1.1 1.7 −1.9 1.4
Th17 4.6 17.6 −1.1 −1.2
TCDD effect (p-value)
excluding Tr1 conditions
0.03 <0.001 0.88 0.82
Data are presented as fold change inTCDD-treated cells relative to vehicle-treated
controls at 24 or 48 h. Data represent 3−4 biological replicates, except for AhR−/−
cells at 24-h Treg and Th17 and 48-h Treg conditions where n=2. Data were ana-
lyzed for significant TCDD-dependent effect across culture conditions, excluding
Tr1.
FIGURE 4 | Influence ofTCDD on Il22 expression under various
polarizing conditions. Data are presented as fold change relative to
expression in Th0 vehicle controls at 24 or 48 h. Error bars represent the
mean±SEM; n=3−4 biological replicates. *p≤0.05.
previous report (Alam et al., 2010). Treatment with TCDD signif-
icantly increased the amount of IL-22 present (p=< 0.001) from
65 pg/ml in vehicle-treated cultures to 374 pg/ml in TCDD-treated
cultures (Figure 5D).
Other statistically significant changes in gene expression
induced by TCDD in differentiating CD4+ T-cells are summarized
in Table 4. Increased expression of Ctla4 (2.3-fold), Cd40lg (2.2-
fold), and Il12rb2 (2.9-fold) was associated with TCDD treatment
at 24 h under Th1 conditions. Il12rb2 was also increased (7.1-fold)
by TCDD under Th17 conditions at 48 h. Under Treg conditions,
only Stat4 expression was altered by TCDD and it was down-
regulated (−2.7-fold), while no changes were seen under Tr1
conditions. Under Th0 conditions, TCDD significantly suppressed
expression of Tbet (2.7-fold) and Il17a (2.1-fold).
INFLUENCE OF AHR DEFICIENCY ON GENE EXPRESSION IN ACTIVATED
CD4+ T-CELLS
Significant changes in gene expression were observed between
vehicle-treated AhR+/+ and AhR−/− CD4+ T-cells cultured under
different polarizing conditions (Figure 6). The most significant
effect of AhR deficiency was increased expression of Il17a at both
24 and 48 h under all culture conditions (Figure 6A). The greatest
up-regulation of Il17a was noted under Treg conditions, with a 53-
fold increase, whereas 16- and 4-fold changes were observed under
Th17 and Tr1 conditions, respectively, at 24 h, with a similar trend
for Th1 and Th0 conditions. At 48 h, Il17a expression was signifi-
cantly up-regulated in AhR−/− CD4+ T-cells under Th1, Treg, and
Tr1 conditions.
Aryl hydrocarbon receptor deficiency also resulted in increased
expression of Rorc, the master transcription factor for Th17 dif-
ferentiation (Figure 6B). At 24 h, AhR−/− T-cells expressed a
sevenfold increase in Rorc under Treg conditions, and a twofold
increase under Th1 and Th17 conditions. Rorc expression was also
increased in AhR−/− cells under Th0 conditions (p= 0.06), while
expression was unaltered under Tr1 polarizing conditions. AhR
regulation of Rorc was no longer seen at 48 h, with the excep-
tion of Tr1 conditions, where Rorc was down-regulated twofold in
AhR−/− CD4+ T-cells.
To determine if the increase in expression of Il17a and Rorc
was observed at the protein level, IL-17A, and RORγ were mea-
sured by flow cytometry in cells cultured under Th17 conditions
for 48 h. As shown in Figure 7A, 1.9% of the AhR+/+ CD4+ T-cells
expressed IL-17A compared to 1.0% of the AhR−/− CD4+ T-cells
(p= 0.05). MFI values were also lower in AhR−/− cells (p= 0.1).
Similarly, a smaller percentage of AhR−/− CD4+ T-cells stained
positive for RORγ compared to AhR+/+ CD4+ T-cells, but the
changes were not statistically significant (p= 0.2; Figure 7B). The
basis for the lack of correlation between gene and protein expres-
sion is not known but may be related to the transient nature of the
up-regulation of Il17a and Rorc expression seen in AhR-deficient
cells. Under Th17 conditions, this effect was most pronounced at
24 h but gone by 48 h. As expected, there was no effect of AhR
status on CD4+ T-cell proliferation, assessed by CFSE dilution.
Aryl hydrocarbon receptor deficiency had no significant effect
on expression of Il22 or Foxp3 under any of the polarizing con-
ditions tested (Figure A2 in Appendix). Tgfb3 and Gzmb were
up-regulated under Treg and Th0 conditions and Il6 was up-
regulated under Treg and Tr1 conditions in AhR-deficient cells,
while other changes were unique to specific culture conditions
(Table 5). In general, the results suggest that AhR deficiency in
CD4+ T-cells favors increased expression of genes associated with
inflammation, consistent with the pro-inflammatory phenotype
of AhR-deficient mice.
DISCUSSION
The AhR is a ligand-activated transcription factor that has been
shown to play a role in CD4+ T-cell differentiation, yet little is
known about the changes in gene expression that occur in these
cells following AhR activation. Previous studies have examined
gene expression in donor CD4+ T-cells isolated from the spleen
of TCDD-treated mice during a GVH response, however the iden-
tification of direct gene targets was confounded by the presence
of contaminating host cells that also express AhR (Marshall et al.,
2008). Identification of gene targets has become more important
as recent reports indicate that there may be ligand-specific effects
of AhR activation on CD4+ T-cell differentiation (Quintana et al.,
2008; Veldhoen et al., 2008). Furthermore, the initial report of
highly increased AhR expression in CD4+ T-cells cultured under
Th17 conditions (Kimura et al., 2008; Veldhoen et al., 2008) led
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FIGURE 5 | Influence ofTCDD on IL-22 protein in CD4+T-cells cultured
underTh17 polarizing conditions for 48 h. Data shown are gated on
viable CD4+ T-cells. (A) CD4+ T-cells were purified and labeled with CFSE
prior to activation. Percent CD4+IL-22+ T-cells are shown. MFI, median
fluorescence intensity. Individual biological replicates are represented
graphically. Histograms shown are representative of 3−4 biological
replicates. (B) Concentration of IL-22 in supernatant from purified CD4+
T-cell cultures.<RL= below reporting limit. (C) Whole spleen cell
suspensions were activated and cultured under Th17 polarizing
conditions, as in (A). (D) Concentration of IL-22 in supernatant from
whole splenocyte cultures. Error bars represent the mean±SEM;
n=3−4 biological replicates. †p=0.06; ‡p=0.08; *p≤0.05.
Table 4 | Summary of changes in expression of immune-related genes
induced byTCDD under different polarizing conditions.
Polarizing
condition
24 hTCDD/vehicle 48 hTCDD/vehicle
Gene Fold
change
p-value Gene Fold
change
p-value
Th0 Il17a −2.1 0.00 No significant changes
Tbet −2.7 0.05
Th1 Il12rb2 2.9 0.06 No significant changes
Ctla4 2.3 0.02
Cd40lg 2.2 0.02
Treg No significant changes Stat4 −2.7 0.01
Tr1 No significant changes No significant changes
Th17 No significant changes Il12rb2 7.1 0.03
Data are presented as fold change inTCDD-treated cells relative to vehicle-treated
controls at 24 or 48 h. None of the changes shown were observed in AhR−/− CD4+
T-cells exposed to TCDD. Data represent 3–4 biological replicates.
to an early misconception that AhR was functional only in Th17
cells in the mouse (Ho and Steinman, 2008; Veldhoen et al., 2008;
Stockinger, 2009; Ramirez et al., 2010). However, more recently,
AhR was shown to be significantly up-regulated in mouse and
human CD4+ T-cells under Tr1 conditions as well (Apetoh et al.,
2010; Gandhi et al., 2010). Given that TCDD suppresses Th1-,
Th2-, and Th17-mediated responses in vivo, it implicates a role
for AhR in the differentiation of many T-cell subsets. The present
studies were designed to determine if genes involved in CD4+
T-cell differentiation are selectively regulated by AhR when the
cells are activated in the presence of TCDD under a variety of
Th-polarizing culture conditions.
The results of our studies show that Ahr is expressed in CD4+
T-cells under all conditions tested, including un-activated cells,
while elevated levels of Ahr are seen under Treg, Tr1, and Th17
conditions. The highest level of Ahr expression was seen under
Th17 conditions at 24 h and Tr1 conditions at 48 h. Functional
AhR protein was also present under all culture conditions based
on the ability of TCDD to induce the expression of known AhR-
regulated genes (Cyp1a1, Cyp1b1, and Ahrr). The level of induced
gene expression was generally proportional to the amount of
Ahr present with the highest induction seen under Th17 con-
ditions. Since many putative endogenous AhR ligands have anti-
inflammatory functions, it suggests that up-regulation of AhR may
be a protective response during highly inflammatory Th17 con-
ditions, allowing low-affinity endogenous AhR ligands to down-
regulate the response, consistent with the effects seen with TCDD.
Examples of low-affinity ligands with immunosuppressive activity
include lipoxin A4, bilirubin, and kynurenine (Sinal and Bend,
1997; Schaldach et al., 1999; Liu et al., 2008; Mezrich et al., 2010).
Indeed, bilirubin and kynurenine have been shown to suppress
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FIGURE 6 | Influence of AhR deficiency on expression of (A) Il17a
or (B) Rorc in AhR+/+ or AhR−/− CD4+ T-cells cultured under
different polarizing conditions for 24 or 48 h. Data are expressed
as fold change relative to AhR+/+ T-cells cultured under vehicle-treated
Th0 conditions. Error bars represent the mean±SEM; n=3 biological
replicates, except for 24 or 48 h AhR−/− Treg conditions, and 24 h Th17
conditions, where n=2. *p≤0.05. ND=not detected within 40
cycles.
EAE and induce CD4+Foxp3+ T-cells, respectively (Liu et al., 2008;
Mezrich et al.,2010). Elevated levels of AhR in CD4+ T-cells under-
going Tr1 and Treg differentiation would also facilitate AhR signal-
ing to promote the development of these anti-inflammatory cells.
TCDD did not appear to alter early polarization of activated
CD4+ T-cells despite strong activation of AhR. Both vehicle- and
TCDD-treated cells showed the expected increase in expression of
Tbet, Foxp3, Maf, and Rorc under Th1, Treg, Tr1, and Th17 polariz-
ing conditions, respectively. Likewise, the expression of other genes
that are associated with specific polarizing conditions was unaf-
fected by TCDD, including Ifng, Cd39, Il10, and Il17a. The lack
of effect of TCDD on Foxp3 expression was somewhat surpris-
ing since TCDD has been previously reported to directly regulate
Foxp3 expression in vitro and increase the generation of Foxp3+
cells (Kimura et al., 2008; Quintana et al., 2008). However, the
lack of effect of TCDD on Foxp3 expression is consistent with
the Foxp3neg Treg phenotype induced by TCDD in vivo (Funatake
et al., 2005; Marshall et al., 2008).
Only a few of the other genes in our 48-gene panel showed
altered expression as a result of the presence of TCDD during
CD4+ T-cell activation. Ctla4 expression was increased by TCDD
under Th1 conditions, a change that is consistent with the AhR-
dependent increase in expression of CTLA-4 on donor CD4+
T-cells in vivo during the GVH response (Funatake et al., 2005).
Likewise, increased expression of Il12rb2 under both Th1 and
Th17 conditions is consistent with the increased responsiveness of
donor CD4+ T-cells from TCDD-treated mice to IL-12, resulting
in enhanced STAT4 phosphorylation (Marshall et al., 2008). Under
Th0 conditions, TCDD also suppressed the expression of Tbet and
Il17a, providing a mechanism to promote Treg differentiation at
the expense of effector Th1 or Th17 cells.
The most noteworthy effect of TCDD in CD4+ T-cells was the
AhR-dependent increase in expression of Il22 that was seen across
all culture conditions except Tr1. AhR-mediated up-regulation of
Il22 was also observed at the protein level in CD4+ T-cells cultured
under Th17 conditions. AhR signaling has been implicated in IL-
22 production in previous studies (Veldhoen et al., 2008; Ramirez
et al., 2010; Rutz et al., 2011). Additionally, Notch signaling was
shown to create AhR ligands that enhance IL-22 production (Alam
et al., 2010). Based on the fact that IL-22 can be produced in the
absence of IL-17A or IFNγ, a unique Th22 subset of CD4+ T-cells
has been proposed (Trifari et al., 2009). The putative transcription
factor for this Th22 subset is the AhR (Trifari et al., 2009). IL-22 has
complex functions and has been shown to produce both inflam-
matory (psoriasis, rheumatoid arthritis) and protective (irritable
bowel disease) responses (reviewed in Zenewicz and Flavell, 2011).
Enhanced production of IL-22 by CD4+ T-cells following AhR
activation by TCDD may play a role in the immunoregulatory
effects of TCDD.
Apart from its role in mediating effects of exogenous lig-
ands such as TCDD, the consequences of AhR activation via
endogenous ligands is also of interest. Although in vivo stud-
ies indicate that AhR−/− mice generate normal adaptive immune
responses to model antigens (Vorderstrasse et al., 2001) and that
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FIGURE 7 | Influence of AhR deficiency on (A) IL-17A or (B) RORγ protein
in AhR+/+ or AhR−/− CD4+ T-cells cultured underTh17 polarizing
conditions for 48 h. Data shown are gated on viable CD4+ T-cells. Percent
IL-17A+ or RORγ+ T-cells are shown. MFI, median fluorescence intensity.
Histograms shown are representative of 3−4 biological replicates. *p≤0.05.
Changes in RORγ expression were not statistically significant.
AhR−/− donor CD4+ T-cells differentiate normally during an
acute GVH response (Kerkvliet et al., 2002; Funatake et al., 2005),
AhR-deficient mice have been reported to express a hypersensitive
phenotype in experimental colitis, and following challenge with
either LPS or cigarette smoke (Thatcher et al., 2007; Sekine et al.,
2009; Furumatsu et al., 2011). Since several putative endogenous
AhR ligands have been associated with the induction of immuno-
suppressive Tregs, the absence of AhR could impair Treg differenti-
ation resulting in hyper-inflammation. Several pro-inflammatory
genes were up-regulated in AhR-deficient cells at 48 h under Treg
polarizing conditions including Ifng, Gzmb, Tgfb3, and Il6 sug-
gesting that the absence of AhR signaling in CD4+ T-cells alters
Treg differentiation. Also consistent with a hypersensitive pheno-
type, CD4+ T-cells from AhR−/−mice showed a transient increase
in expression of genes associated with Th17 differentiation, Rorc,
and Il17a, which was seen under Th1, Treg, Tr1, and Th17 condi-
tions at 24 h. However, neither transcript nor protein levels were
affected at 48 h when measured under Th17 conditions. These
results suggest that the impairment of Th17 differentiation in the
absence of AhR (Kimura et al., 2008; Veldhoen et al., 2009) results
from post-transcriptional events. Similarly, whereas Kimura et al.
(2008) reported that fewer Foxp3+ cells were generated when
AhR−/− cells were cultured under Treg conditions, AhR deficiency
did not influence Foxp3 expression under any of the conditions
tested in our studies.
Given the emerging role of AhR in IL-22 production and the
significant up-regulation of Il22 by TCDD, we were surprised to
find that AhR deficiency did not impair expression of the Il22
gene. This finding was in direct contrast to the results of Veldhoen
et al. (2008) who first reported that IL-22 expression was absent
in AhR-deficient cells (Veldhoen et al., 2008). One possible expla-
nation for these divergent findings may derive from the type of
media used for T-cell culture. All of our studies utilized RPMI 1640
whereas Veldhoen et al. (2008) may have used a specific medium
(IMDM) that contains high levels of aromatic amino acids includ-
ing tryptophan, a source of several AhR ligands (Veldhoen et al.,
2009). If IMDM was used, the expression of Il22 may have been
up-regulated in WT cells due to the presence of endogenous AhR
ligands, while AhR-deficient cells would be unable to respond.
We saw this effect when we compared IL-22 expression in Th17-
polarized cultures of AhR+/+ and AhR−/− CD4+ T-cells treated
with TCDD. Expression of Il22 was more than 50-fold higher in
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Table 5 | Summary of changes in expression in immune-related genes
related to AhR deficiency in CD4+ T-cells cultured under different
polarizing conditions.
Polarizing
condition
24 h AhR−/−/AhR+/+ 48 h AhR−/−/AhR+/+
Gene Fold
change
p-value Gene Fold
change
p-value
Th0 Nfatc2 2.9 0.04 Tgfb3 6.0 0.01
Cd27 −2.2 0.05 Gzmb 2.4 0.02
Cd69 −2.1 0.02
Th1 Ox40 2.6 0.01 No significant changes
Cd25 2.3 0.05
Treg Il2 6.0 0.02 Ifng 3.9 0.04
Gzmb 3.6 0.01
Tgfb3 3.1 0.05
Il6 3.0 0.05
Cd25 2.1 0.05
Cd69 −3.0 0.02
Stat4 −5.8 0.03
Tr1 No significant changes Il6 3.4 0.04
Tgfbr1 2.1 0.01
Adora2b 2.2 0.00
Th17 No significant changes Il2 −5.0 0.01
Data are presented as fold change in AhR−/− CD4+ T-cells relative to AhR+/+ CD4+
T-cells at 24 or 48 h. Data represent 3–4 biological replicates, except for AhR−/−
cells at 24-h Treg and Th17 and 48-h Treg conditions where n=2.
AhR+/+ cells at 48 h (unpublished observations). Our data suggest
that AhR is not needed for constitutive IL-22 expression.
In summary, strong activation of AhR by TCDD in differenti-
ating CD4+ T-cells failed to influence the expression of numerous
genes associated with T-cell activation and differentiation. Since
many of these genes have been shown to be altered by TCDD in
differentiating CD4+ T-cells in vivo, the results cast doubt on the
ability of in vitro conditions to recapitulate in vivo events. This
could be due to lack of accessory cell signals not mimicked by
antibodies to CD3 and CD28, or to the presence of high levels of
polarizing cytokines that might dominate the signaling pathways.
Other than known AhR-regulated genes (Cyp1a1, Cyp1b1, Ahrr),
the only immune-related gene that was clearly regulated by AhR
in CD4+ T-cells was Il22, a gene that has been recently associated
with the AhR pathway. The possible role that IL-22 plays in the
immunoregulatory effects of TCDD awaits future studies.
ACKNOWLEDGMENTS
We would like to thank Jamie Pennington and Sumit Punj for
critical reading of the manuscript, as well as Sam Bradford for assis-
tance with experiments involving flow cytometry. We also thank
Cliff Pereira for help with statistical analysis. We also acknowledge
the services provided by the Cell and Tissue Analysis Facilities and
Services Core of the Environmental Health Sciences Center, Ore-
gon State University, NIEHS Grant number P30ES000210. This
work was supported by the National Institute of Environmental
Health Sciences, National Institutes of Health [Grant numbers
5R01ES016651 and T32ES007060].
REFERENCES
Alam, M. S., Maekawa, Y., Kitamura, A.,
Tanigaki, K., Yoshimoto, T., Kishi-
hara, K., and Yasutomo, K. (2010).
Notch signaling drives IL-22 secre-
tion in CD4+ T cells by stimulat-
ing the aryl hydrocarbon receptor.
Proc. Natl. Acad. Sci. U.S.A. 107,
5943–5948.
Apetoh, L., Quintana, F., Pot, C., Joller,
N., Xiao, S., Kumar, D., Burns, E.,
Sherr, D., Weiner, H., and Kuchroo,
V. (2010). The aryl hydrocarbon
receptor interacts with c-Maf to pro-
mote the differentiation of type 1
regulatory T cells induced by IL-27.
Nat. Immunol. 11, 854–861.
Benson, J. M., and Shepherd, D. M.
(2011). Aryl hydrocarbon receptor
activation by TCDD reduces inflam-
mation associated with Crohn’s dis-
ease. Toxicol. Sci. 120, 68–78.
Frericks, M., Burgoon, L. D.,
Zacharewski, T. R., and Esser,
C. (2008). Promoter analysis of
TCDD-inducible genes in a thymic
epithelial cell line indicates the
potential for cell-specific transcrip-
tion factor crosstalk in the AhR
response. Toxicol. Appl. Pharmacol.
232, 268–279.
Fujimaki, H., Nohara, K., Kobayashi,
T., Suzuki, K., Eguchi-Kasai, K.,
Tsukumo, S., Kijima, M., and
Tohyama, C. (2002). Effect of
a single oral dose of 2,3,7,8-
tetrachlorodibenzo-p-dioxin on
immune function in male NC/Nga
mice. Toxicol. Sci. 66, 117–124.
Funatake, C. J., Marshall, N. B.,
Steppan, L. B., Mourich, D. V.,
and Kerkvliet, N. I. (2005). Cut-
ting Edge: activation of the aryl
hydrocarbon receptor by 2,3,7,8-
tetrachlorodibenzo-p-dioxin gener-
ates a population of CD4+CD25+
cells with characteristics of regu-
latory T Cells. J. Immunol. 175,
4184–4188.
Furumatsu, K., Nishiumi, S., Kawano,
Y., Ooi, M., Yoshie, T., Shiomi,
Y., Kutsumi, H., Ashida, H., Fujii-
Kuriyama, Y., Azuma, T., and
Yoshida, M. (2011). “A role of the
aryl hydrocarbon receptor in attenu-
ation of colitis,” in Digestive Diseases
and Sciences, Vol. 56 (Dordrecht:
Springer), 2532–2544.
Gandhi, R., Kumar, D., Burns, E. J.,
Nadeau, M., Dake, B., Laroni, A.,
Kozoriz, D., Weiner, H. L., and Quin-
tana, F. J. (2010). Activation of the
aryl hydrocarbon receptor induces
human type 1 regulatory T cell-like
and Foxp3+ regulatory T cells. Nat.
Immunol. 11, 846–853.
Hermann-Kleiter, N., and Baier, G.
(2010). NFAT pulls the strings
during CD4+ T helper cell
effector functions. Blood 115,
2989–2997.
Ho, P. P., and Steinman, L. (2008). The
aryl hydrocarbon receptor: a regu-
lator of Th17 and Treg cell devel-
opment in disease. Cell Res. 18,
605–608.
Kerkvliet, N. I. (2009). AHR-mediated
immunomodulation: the role of
altered gene transcription. Biochem.
Pharmacol. 77, 746–760.
Kerkvliet, N. I., Baecher-Steppan, L.,
Shepherd, D. M., Oughton, J. A.,
Vorderstrasse, B. A., and DeKrey,
G. K. (1996). Inhibition of TC-
1 cytokine production, effector
cytotoxic T lymphocyte develop-
ment and alloantibody production
by 2,3,7,8-tetrachlorodibenzo-
p-dioxin. J. Immunol. 157,
2310–2319.
Kerkvliet, N. I., Shepherd, D.
M., and Baecher-Steppan, L.
(2002). T lymphocytes are
direct, aryl hydrocarbon recep-
tor (AhR)-dependent targets of
2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD): AhR expression in
both CD4+ and CD8+ T cells is
necessary for full suppression of a
cytotoxic T lymphocyte response
by TCDD. Toxicol. Appl. Pharmacol.
185, 146–152.
Kerkvliet, N. I., Steppan, L. B.,Vorachek,
W., Oda, S., Farrer, D., Wong, C.
P., Pham, D., and Mourich, D. V.
(2009). Activation of aryl hydrocar-
bon receptor by TCDD prevents dia-
betes in NOD mice and increases
Foxp3+ T cells in pancreatic lymph
nodes. Immunotherapy 1, 539–547.
Kimura, A., Naka, T., Nohara, K., Fujii-
Kuriyama, Y., and Kishimoto, T.
(2008). Aryl hydrocarbon receptor
regulates Stat1 activation and par-
ticipates in the development of Th17
cells. Proc. Natl. Acad. Sci. U.S.A. 105,
9721–9726.
Liu, Y., Li, P., Lu, J., Xiong, W., Oger,
J., Tetzlaff, W., and Cynader, M.
(2008). Bilirubin possesses pow-
erful immunomodulatory activ-
ity and suppresses experimental
autoimmune encephalomyelitis. J.
Immunol. 181, 1887–1897.
Frontiers in Immunology | T Cell Biology August 2012 | Volume 3 | Article 223 | 10
Rohlman et al. AhR-regulated gene expression in CD4+ T-cells
Luebke, R. W., Copeland, C. B., Daniels,
M., Lambert, A. L., and Gilmour,
M. I. (2001). Suppression of aller-
gic immune responses to house
dust mite (HDM) in rats exposed
to 2,3,7,8-TCDD. Toxicol. Sci. 62,
71–79.
Marshall, N. B., Vorachek, W. R.,
Steppan, L. B., Mourich, D. V.,
and Kerkvliet, N. I. (2008). Func-
tional characterization and gene
expression analysis of CD4+
CD25+ regulatory T cells generated
in mice treated with 2,3,7,8-
tetrachlorodibenzo-p-dioxin. J.
Immunol. 181, 2382–2391.
Mezrich, J. D., Fechner, J. H., Zhang,
X., Johnson, B. P., Burlingham, W. J.,
and Bradfield, C. A. (2010). An inter-
action between kynurenine and the
aryl hydrocarbon receptor can gen-
erate regulatory T Cells. J. Immunol.
185, 3190–3198.
Nohara, K., Fujimaki, H., Tsukumo,
S. I., Inouye, K., Sone, H., and
Tohyama, C. (2002). Effects of
2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) on T cell-derived
cytokine production in ovalbumin
(OVA)-immunized C57Bl/6 mice.
Toxicology 172, 49–58.
Quintana, F. J., Basso, A. S., Iglesias, A.
H., Korn, T., Farez, M. F., Bettelli,
E., Caccamo, M., Oukka, M., and
Weiner, H. L. (2008). Control of Treg
and TH17 cell differentiation by the
aryl hydrocarbon receptor. Nature
453, 65–71.
Ramirez, J.-M., Brembilla, N. C., Sorg,
O., Chicheportiche, R., Matthes, T.,
Dayer, J.-M., Saurat, J.-H., Roos-
nek, E., and Chizzolini, C. (2010).
Activation of the aryl hydrocar-
bon receptor reveals distinct require-
ments for IL-22 and IL-17 produc-
tion by human T helper cells. Eur. J.
Immunol. 40, 2450–2459.
Rutz, S., Noubade, R., Eidenschenk,
C., Ota, N., Zeng, W., Zheng,
Y., Hackney, J., Ding, J., Singh,
H., and Ouyang, W. (2011).
Transcription factor c-Maf mediates
the TGF-[beta]-dependent suppres-
sion of IL-22 production in TH17
cells. Nat. Immunol. 12, 1238–1245.
Schaldach, C. M., Riby, J., and Bjel-
danes, L. F. (1999). Lipoxin A4: a new
class of ligand for the Ah receptor.
Biochemistry 38, 7594–7600.
Schulz, V. J., Smit, J. J., Willemsen, K.
J., Fiechter, D., Hassing, I., Bleu-
mink, R., Boon, L., van den Berg,
M., van Duursen, M. B. M., and
Pieters, R. H. H. (2011). Activation
of the aryl hydrocarbon receptor
suppresses sensitization in a mouse
peanut allergy model. Toxicol. Sci.
123, 491–500.
Sekine, H., Mimura, J., Oshima, M.,
Okawa, H., Kanno, J., Igarashi, K.,
Gonzalez, F. J., Ikuta, T., Kawajiri,
K., and Fujii-Kuriyama, Y. (2009).
Hypersensitivity of aryl hydro-
carbon receptor-deficient mice to
Lipopolysaccharide-induced septic
shock. Mol. Cell. Biol. 29, 6391–6400.
Shepherd, D. M., Dearstyne, E. A., and
Kerkvliet, N. I. (2000). The effects of
TCDD on the activation of ovalbu-
min (OVA)-specific DO11.10 trans-
genic CD4(+) T cells in adoptively
transferred mice. Toxicol. Sci. 56,
340–350.
Sinal, C. J., and Bend, J. R. (1997). Aryl
hydrocarbon receptor-dependent
induction of cyp1a1 by bilirubin in
mouse hepatoma hepa 1c1c7 cells.
Mol. Pharmacol. 52, 590–599.
Singh, N. P., Singh, U. P., Singh, B.,
Price, R. L., Nagarkatti, M., and
Nagarkatti, P. S. (2011). Activation
of aryl hydrocarbon receptor (AhR)
leads to reciprocal epigenetic regu-
lation of Foxp3 and IL-17 expres-
sion and amelioration of experi-
mental colitis. PLoS ONE 6, e23522.
doi:10.1371/journal.pone.0023522
Stockinger, B. M. V. (2009). Beyond
toxicity: aryl hydrocarbon receptor-
mediated functions in the immune
system. J. Biol. 8, 61.
Sun, Y. V., Boverhof, D. R., Burgoon, L.
D., Fielden, M. R., and Zacharewski,
T. R. (2004). Comparative analysis of
dioxin response elements in human,
mouse and rat genomic sequences.
Nucleic Acids Res. 32, 4512–4523.
Takamura, T., Harama, D., Matsuoka, S.,
Shimokawa, N., Nakamura, Y., Oku-
mura, K., Ogawa, H., Kitamura, M.,
and Nakao, A. (2010). Activation of
the aryl hydrocarbon pathway may
ameliorate dextran sodium sulfate-
induced colitis in mice. Immunol.
Cell Biol. 88, 685–689.
Thatcher, T. H., Maggirwar, S. B.,
Baglole, C. J., Lakatos, H. F.,
Gasiewicz, T. A., Phipps, R. P., and
Sime, P. J. (2007). Aryl hydrocar-
bon receptor-deficient mice develop
heightened inflammatory responses
to cigarette smoke and endotoxin
associated with rapid loss of the
nuclear factor-[kappa]B component
RelB. Am. J. Pathol. 170, 855–864.
Trifari, S., Kaplan, C. D., Tran, E. H.,
Crellin, N. K., and Spits, H. (2009).
Identification of a human helper T
cell population that has abundant
production of interleukin 22 and is
distinct from TH-17, TH1 and TH2
cells. Nat. Immunol. 10, 864–871.
Veldhoen, M., Hirota, K., Christensen,
J., O’Garra, A., and Stockinger, B.
(2009). Natural agonists for aryl
hydrocarbon receptor in culture
medium are essential for optimal
differentiation of Th17 T cells. J. Exp.
Med. 206, 43–49.
Veldhoen, M., Hirota, K., Westendorf, A.
M., Buer, J., Dumoutier, L., Renauld,
J.-C., and Stockinger, B. (2008).
The aryl hydrocarbon receptor links
TH17-cell-mediated autoimmunity
to environmental toxins. Nature 453,
106–109.
Vorderstrasse, B. A., Steppan, L. B., Sil-
verstone, A. E., and Kerkvliet, N. I.
(2001). Aryl hydrocarbon receptor-
deficient mice generate normal
immune responses to model anti-
gens and are resistant to TCDD-
induced immune suppression. Tox-
icol. Appl. Pharmacol. 171, 157–164.
Warren, T. K., Mitchell, K. A., and
Lawrence, B. P. (2000). Exposure
to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) suppresses the
humoral and cell-mediated immune
responses to Influenza A virus
without affecting cytolytic activity
in the lung. Toxicol. Sci. 56, 114–123.
Zenewicz,L. A., and Flavell,R. A. (2011).
Recent advances in IL-22 biology.
Int. Immunol. 23, 159–163.
Zhang, L., Ma, J., Takeuchi, M., Usui, Y.,
Hattori, T., Okunuki, Y., Yamakawa,
N.,Kezuka,T.,Kuroda,M.,and Goto,
H. (2010). Suppression of experi-
mental autoimmune uveoretinitis by
inducing differentiation of regula-
tory T Cells via activation of aryl
hydrocarbon receptor. Invest. Oph-
thalmol. Vis. Sci. 51, 2109–2117.
Zhou, L., Chong, M. M. W., and
Littman, D. R. (2009). Plasticity of
CD4+ T cell lineage differentiation.
Immunity 30, 646–655.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 03 May 2012; accepted: 10 July
2012; published online: 06 August 2012.
Citation: Rohlman D, Pham D, Yu Z,
Steppan LB and Kerkvliet NI (2012)
Aryl hydrocarbon receptor-mediated per-
turbations in gene expression during
early stages of CD4+ T-cell differ-
entiation. Front. Immun. 3:223. doi:
10.3389/fimmu.2012.00223
This article was submitted to Frontiers in
T Cell Biology, a specialty of Frontiers in
Immunology.
Copyright © 2012 Rohlman, Pham, Yu,
Steppan and Kerkvliet . This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
www.frontiersin.org August 2012 | Volume 3 | Article 223 | 11
Rohlman et al. AhR-regulated gene expression in CD4+ T-cells
APPENDIX
FIGURE A1 | Expression of Cyp1b1 andAhrr in AhR+/+ CD4+ T-cells
treated with vehicle orTCDD. Data are presented as fold change
calculated relative to Th0 vehicle at (A) 24 or (B) 48 h. Expression of Cyp1b1
at 48 h in Th0 vehicle was greater than 40 cycles; a value of 40 was used to
calculate fold changes. Error bars represent the mean±SEM; n= 3−4
biological replicates. *p≤0.05 relative to the vehicle control. ND=not
detected.
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FIGURE A2 | Expression of Il22 and Foxp3 in AhR+/+ and AhR−/−
CD4+ T-cells cultured under different polarizing conditions. Data are
presented as fold change calculated relative to AhR+/+ T-cells cultured
under vehicle-treated Th0 conditions. Expression of (A) Il22 and (B)
Foxp3 in AhR+/+ and AhR−/− cells at 24 and 48 h. Error bars represent
the mean±SEM; n= 3 biological replicates except for 24 and 48 h
AhR−/− Treg conditions, and 24 h Th17 polarizing conditions, where
n= 2. *p≤0.05.
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